Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Uchimaru

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2016
Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall MortalityShigeo Fuji, Yoshitaka Inoue, Atae Utsunomiya, et al.
Haematologica|March 26, 2017
Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantationShigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|August 27, 2025
Bridging therapy with valemetostat to allogeneic hematopoietic cell transplantation for adult T-cell leukemia/lymphomaShota Furukawa, Ayumu Ito, Koji Jimbo, et al.
British Journal of Haematology|August 26, 2004
Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 yearsJun Ooi, Tohru Iseki, Satoshi Takahashi, et al.
Nature Communications|November 10, 2025
Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic interventionMakoto Nakashima, Kaho Nagai, Naoki Takao, et al.
Cancer Science|September 25, 2020
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
International Journal of Hematology|October 29, 2022
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
Cancer Science|September 15, 2017
Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide surveyKisato Nosaka, Masako Iwanaga, Yoshitaka Imaizumi, et al.
International Journal of Hematology|September 2, 2025
Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in TokyoJunya Makiyama, Nobuhiro Ohno, Koji Jimbo, et al.
Blood|March 25, 2004
A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemiaYasushi Soda, Kenzaburo Tani, Yuansong Bai, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2016
Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall MortalityShigeo Fuji, Yoshitaka Inoue, Atae Utsunomiya, et al.
Haematologica|March 26, 2017
Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantationShigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|August 27, 2025
Bridging therapy with valemetostat to allogeneic hematopoietic cell transplantation for adult T-cell leukemia/lymphomaShota Furukawa, Ayumu Ito, Koji Jimbo, et al.
British Journal of Haematology|August 26, 2004
Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 yearsJun Ooi, Tohru Iseki, Satoshi Takahashi, et al.
Nature Communications|November 10, 2025
Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic interventionMakoto Nakashima, Kaho Nagai, Naoki Takao, et al.
Cancer Science|September 25, 2020
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
International Journal of Hematology|October 29, 2022
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter studyYoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, et al.
Cancer Science|September 15, 2017
Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide surveyKisato Nosaka, Masako Iwanaga, Yoshitaka Imaizumi, et al.
International Journal of Hematology|September 2, 2025
Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in TokyoJunya Makiyama, Nobuhiro Ohno, Koji Jimbo, et al.
Blood|March 25, 2004
A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemiaYasushi Soda, Kenzaburo Tani, Yuansong Bai, et al.
Pageof 14